2026年8月30日•1分で読めます
FDA scientists caution against easing peptide drug regulations for compounding pharmacies
FDA internal scientists advise against loosening controls on seven peptide ingredients intended for ulcerative colitis, insomnia and obesity, citing insufficient safety data.